Carregando...
Challenges of transarterial therapy for hepatocellular carcinoma in patients with chronic kidney disease
Poor outcomes of hepatocellular carcinomas (HCC) in chronic kidney disease (CKD) patients are well described. Transarterial therapy is the standard treatment for HCC, following which regular contrast-enhanced imaging for residual disease is recommended. CKD is considered a relative contraindication...
Na minha lista:
| Publicado no: | Medicine (Baltimore) |
|---|---|
| Principais autores: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Wolters Kluwer Health
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6736401/ https://ncbi.nlm.nih.gov/pubmed/31464957 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000017007 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|